Brief: Eckert & Ziegler Q3 Profit At EUR 9.4 Mln

Eckert & Ziegler SE

17/10/2023 16:01

Oct 17 (Reuters) - ECKERT & ZIEGLER STRAHLEN UND
MEDIZINTECHNIK AG  EUZG.DE :
    * ECKERT & ZIEGLER ACHIEVES DOUBLE-DIGIT GROWTH IN Q3 VERSUS
PREVIOUS YEAR. SIGNIFICANT JUMP IN SALES ALSO IN FIRST 9 MONTHS,
EARNINGS STILL BURDENED BY SPECIAL ITEMS COMPARED TO SAME PERIOD
LAST YEAR.
    * Q3 SALES OF 65.9 MILLION EUR (PREVIOUS YEAR: 57.2 MILLION
EUR)
    * Q3 PROFIT OF 9.4 MILLION EUR (PREVIOUS YEAR: 7.9 MILLION
EUR)
    * 9M PROFIT OF 20.3 MILLION EUR (PREVIOUS YEAR: 23.3 MILLION
EUR)
    * OUTLOOK 2023: SALES OF JUST UNDER 230 MILLION EUR
(CONFIRMED)
    * OUTLOOK 2023: PROFIT OF AROUND EUR 25 MILLION (CONFIRMED)
    * OUTLOOK 2023: MAIN DRIVER OF THIS DEVELOPMENT IS
CONTINUING
DEMAND FOR RADIOISOTOPES FOR PHARMACEUTICAL APPLICATIONS, WHICH
LED TO GROWTH OF AROUND 27% IN MEDICAL SEGMENT
    * OUTLOOK 2023: MAIN DRIVERS OF DECLINE IN EARNINGS COMPARED
TO
PREVIOUS YEAR ARE CURRENCY EFFECTS AS WELL AS INFLATION
ADJUSTMENTS IN HYPERINFLATIONARY COUNTRY OF ARGENTINA
    * OUTLOOK 2023: THESE AMOUNT TO AROUND 4.5 MILLION EUR

Source text for Eikon:  ID:nEQ9qwxfda 
Further company coverage:  EUZG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))